Corindus Vascular Robotics Inc (NYSE:CVRS) target price raised to $3.00, reported today by B. Riley
- Updated: October 7, 2016
Yesterday Corindus Vascular Robotics Inc (NYSE:CVRS) traded 1.83% higher at $1.11. The company’s 50-day moving average is $1.20 and its 200-day moving average is $1.23. The last stock close price is down -9.86% from the 200-day moving average, compared to the S&P 500 which has decreased -0.01% over the same time. 61,721 shares of the stock were exchanged, down from an average trading volume of 118,586
Corindus Vascular Robotics Inc (NYSE:CVRS) had its target price raised to $3.00 by B. Riley in a report released 10/07/2016. The new target price indicates a possible upside of 1.70% based on the company's last stock close price.
Previously on 4/20/2016, Sterne Agee reported about Corindus Vascular Robotics Inc (NYSE:CVRS) raised the target price from $0.00 to $3.00. At the time, this indicated a possible upside of 1.63%.
See Chart Below
Corindus Vascular Robotics Inc has a 52 week low of $0.73 and a 52 week high of $3.50 The company’s market cap is currently $0.
In addition to B. Riley reporting its target price, a total of 2 firms have reported on the stock. The consensus target price is $3.25 with 0 firms rating the stock a strong buy, 0 firms rating the stock a buy, 0 firms rating the stock a hold, 0 firms rating the stock a underperform, and finally 0 firms rating the stock a sell.
About Corindus Vascular Robotics Inc (NYSE:CVRS)
Corindus Vascular Robotics, Inc. designs, manufactures and sells precision vascular robotic-assisted systems for use in interventional vascular procedures (the CorPath System). The Company operates through the development, marketing and sales of robotic-assisted vascular interventions segment. The Company's product, the CorPath 200 System, is a vascular robotic system, which is engaged in stent placement in percutaneous coronary intervention (PCI) procedures. The CorPath System enables the robotic-assisted control of coronary guidewires and balloon/stent devices from the safety of a radiation-protected, ergonomic interventional cockpit. The CorPath System consists of two components: a bedside unit and an interventional cockpit. At the bedside, the CorPath System's robotic drive and sterile, single-use cassette (CorPath Cassette) translate the physician's commands into movements and manipulations of the coronary stents and catheters.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.